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BiomarkerPeroxiredoxin 2 (Prx2) is the third most abundant protein in red blood cells (RBCs). In this study, we
have succeeded in implementing the rapid and simultaneous detection of the hyperoxidized
(Prx2-SO2/3) and reduced (Prx2-SH) forms of Prx2 in human RBCs using reverse phase high-
performance liquid chromatography. The detection of a peak corresponding to Prx2-SO2/3 was
clearly observed following treatment of tert-butyl hydroperoxide (t-BHP), but not H2O2, and was
found to be dose-dependent. The identity of the peak was conﬁrmed as Prx2 by immunoblotting
and mass spectrometry analysis. Our results suggest that t-BHP hyperoxidizes cysteine residues in
Prx2 more readily than H2O2, and that accumulation of hyperoxidized Prx2 might reﬂect disruption
of redox homeostasis in RBCs.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Peroxiredoxins (Prxs) constitute a group of redox enzymes that
eliminate hydrogen peroxide using thioredoxin as the substrate;
the isoforms Prx1–6 have been identiﬁed in recent studies [1]. Prxs
contain cysteine residues that are highly sensitive to oxidation by
peroxides [2]. It is also known that Prxs react with low level H2O2
at cysteine residues in the active site [2]. In cells, the oxidation
state (disulﬁde form or reduced monomer) of cysteine residues is
reversely regulated by the thioredoxin- and sulﬁredoxin-
dependent reductase systems [3]. However, the contribution of
the reductase systems in human red blood cells (RBCs) remains u
nclear [4,5]. Prxs are antioxidative proteins and Prx2 has been
the focus of attention as a possible oxidative stress marker [6,7].
Indeed, certain studies have reported that hyperoxidized Prx2
can serve as an indicator of oxidation in blood preservation [8,9].
Additionally, the hyperoxidized forms of Prx family proteins havebeen found in neuronal cells [10] and the brains of patients with
Alzheimer’s disease [11]. Although notable and interesting reports
focusing on the oxidation of Prx2 are steadily increasing, the
oxidation state and physiological formation process of irreversibly
oxidized Prx2, termed the ‘‘hyperoxidized form’’, are not well
understood in human RBCs.
In this study, we assessed a possible method for detecting oxi-
dation of Prx2, which is an abundant protein in RBCs. The produc-
tion of hyperoxidized Prx2 in reactions with hydrogen peroxide
(H2O2) and tert-butyl hydroperoxide (t-BHP) was investigated to
establish a reverse-phase mode high performance liquid chroma-
tography (HPLC)-based procedure for the separation and UV detec-
tion of the reduced and hyperoxidized forms of Prx2. Further, we
conducted a more detailed analysis focusing on the oxidation state
of susceptible thiol residues in hyperoxidized Prx2 produced by the
treatment of human RBCs with t-BHP using speciﬁc antibody and
mass spectrometry (MS) techniques.
2. Materials and methods
2.1. Chemicals
RIPA solution, tert-butyl hydroperoxide (t-BHP), and 3-amino-
1,2,4-triazol (3-AT) were purchased from Sigma Aldrich (St. Louis,
MO, USA). Dithiothreitol (DTT), mercaptosuccinate and hydrogen
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Wako Pure Chemical Industries (Osaka, Japan). The protease inhib-
itor cocktail was obtained from Thermo Scientiﬁc (Waltham, MA,
USA). HPLC grade water and acetonitrile were obtained from Nac-
alai Tesque (Kyoto, Japan). All other reagents were of the highest
commercial grade available.
2.2. Preparation of RBCs and lysates
Blood samples were obtained from eight healthy subjects
(21–51 years old; fasted for 12 h) with their informed consent.
Bloodwas drawn into vacutainer tubes containing ethylenediamine
tetraacetic acid (EDTA). RBCs were prepared by centrifugation at
800g for 10 min at 4 C and were washed in phosphate-buffered
saline [PBS: 137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl,
1.47 mM KH2PO4 (pH 7.4)] using the same centrifugation proce-
dure. RBCs were resuspended in PBS (Hct. 0.40) containing 10 mM
glucose and 1 mM diethylenetriaminepentaacetic acid (DTPA).
To avoid the artiﬁcial oxidation of Prx2 during the direct analy-
sis of the hemolysate by reverse phase HPLC assay, RBCs were
lysed in a hypotonic buffer [5 mM phosphate buffer (pH 7.4) con-
taining 0.1% Triton-X 100, protease inhibitors] containing 5 mM
DTT after incubation with or without each peroxide. The lysates
were centrifuged at 15,000g for 5 min at 4 C and the supernatant
was used as the sample for analysis of Prx2. All of the hemolysates
were prepared within 60 min of collection and were subsequently
rapidly separated using HPLC.
2.3. Hyperoxidation of Prx2 in RBCs
Irreversible oxidation of Prx2 was induced by H2O2 or t-BHP
treatment. The RBC suspension (hematocrit adjusted to 40%) was
incubated at 37 C with 100–500 lM peroxides for 60 min, after
which the RBCs were washed twice in PBS. Following hemolysis
of the RBCs in a hypotonic buffer, the hemolysate was centrifuged
to remove insoluble debris. The supernatant was immediately
applied to a reverse phase HPLC system for protein separation.
2.4. HPLC system
Reverse phase HPLC was performed using a C18 column for pro-
tein (YMC-packed PROTEIN-RP; YMC Co., Tokyo, Japan) with a UV
detector (280 nm). The RBC lysate was injected into the column,
which was equilibrated with 40% acetonitrile, at a ﬂow rate of
1.0 ml/min. HPLCwas conducted using twomobile phases, A [water
containing 0.1% triﬂuoroacetic acid (TFA)] and B (acetonitrile
containing 0.1% TFA). The elution was conducted according to the
following sequence: 40% B (0 min) – 40% B (20 min) – 45% B
(50 min) – 90% B (50.1 min) – 90% B (60 min) – 40% B (60.1 min)
– 40% B (70 min).
2.5. Western blot analysis and detection of Prx2 and Prx-SO2/3
Equal amounts of protein were subjected to SDS–PAGE (Any KD
gel; Bio-Rad, Hercules, CA, USA) with (reducing condition) or with-
out (non-reducing condition) DTT-reduction. For the immunoblot
analyses of Prx2 and hyperoxidized Prx2 (Prx-SO2/3), the proteins
were electrophoretically transferred to a polyvinylidene diﬂuoride
(PVDF) membrane; the membranes were blocked with 0.1% (w/v)
skim milk containing TPBS [0.1% Tween (v/v) containing PBS (pH
7.4)], and were subsequently washed three times with TPBS. The
washed PVDF membranes were then incubated for 1 h at room
temperature with anti-Prx2 antibody (monoclonal; Abfrontier,
South Korea) or an anti-Prx-SO2/3 antibody (polyclonal; Abfron-
tier). After extensive washing in TPBS, the blots were incubated
at room temperature for 1 h with anti-mouse or anti-rabbit IgGhorseradish peroxidase-conjugated secondary antibody (Vector,
Burlingame, CA, USA). The band images were captured using
chemiluminescence reagents (Immobilon; Merck Millipore,
Darmstadt, Germany) with an ImageQuant 400 (GE Healthcare,
Japan Ltd., Tokyo, Japan).
2.6. Two-dimensional SDS–PAGE
Cell lysates or puriﬁed proteins were mixed with rehydration
buffer (8 M urea, 2% CHAPS, 0.5% immobilized pH gradient buffer,
20 mM DTT, and 0.005% bromophenol blue) and loaded onto
immobilized pH gradient strips (pH 4–7, 7 cm, Ready Strip IPG;
Bio-Rad). Isoelectric focusing was carried out in four steps as fol-
lows: 250 V, 15 min; 4000 V, 1.0 h; 4000 V, 8–10,000 V-h, 500 V,
24 h. After reduction and alkylation, second dimensional electro-
phoresis was conducted on an SDS–PAGE with a 5–20% gradient
gel (ATTO, Tokyo, Japan).
2.7. Protein identiﬁcation
Identiﬁcation of the proteins of interest was performed by in-
gel digestion and peptide mass ﬁnger printing (PMF) using MS as
described previously, with some modiﬁcations [12,13]. Brieﬂy, gels
were stained with a Silver Stain MS Kit (Wako Pure Chemical
Industries) and the protein bands of interest were excised. The
gel pieces were destained in a 1:1 solution of 100 mM sodium
thiosulfate and 30 mM potassium ferricyanide and subsequently
incubated in a reducing solution (25 mM NH4HCO3 and 25 mM
DTT) for 20 min at 56 C, followed by further incubation for
20 min at room temperature in an alkylation solution (25 mMNH4-
HCO3 and 55 mM iodoacetamide). The gel pieces were dehydrated
with acetonitrile and incubated in 20 ll of digestion solution
[50 mM NH4HCO3, 2 lg/ml trypsin (Trypsin Gold, mass spectrom-
etry grade; Promega, Madison, WI, USA) and 0.01% ProteaseMax
(Promega)] for 10 min at room temperature, followed by the addi-
tion of 10 ll digestion solution without trypsin. After incubation
for 3 h at 42 C, the peptides produced were extracted with 2.5%
TFA and spectra were obtained using matrix-assisted laser desorp-
tion/ionization (MALDI)–time of ﬂight (TOF)–TOF-MS (UltraﬂeX-
treme; Bruker Daltonics, Bremen, Germany). The data set was
entered into an in-house Mascot search engine (Matrix Sciences,
London, UK) to ﬁnd the closest match with known proteins
registered in the Swiss-Prot database.
2.8. Other methods
Protein concentrations were determined using a BCA kit
(Thermo Scientiﬁc) with bovine serum albumin as a standard.
3. Results
First, we investigated the separation conditions for Prx2 in RBC
lysates using reverse-phase columns for protein separation. The
eluted fractions were subjected to SDS–PAGE, followed by Western
blotting detection with anti-Prx2 antibodies. Fig. 1A shows a chro-
matogram of lysates from native RBCs and the separation pattern
of Prx2. Using the gradient program that we established in this
study, Prx2 was detected at a retention time of 42 min (Peak-a,
Fig. 1A). Additionally, a minor band was observed at a retention
time of 46 min. We next examined the effect of oxidative stress
on Prx2 elution using the commonly employed oxidant H2O2.
Compared to control (Fig. 1A), changes in the chromatogram and
separation pattern of Prx2 were not prominent in H2O2-treated
RBCs (Fig. 1B), although the low intensity Prx2 band at a retention
time of 46 min tended to increase. Following pretreatment with
inhibitors (10 mM 3-AT for catalase, 7 mM succinate for GPx1)
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Fig. 1. Chromatograms of human RBC lysate as analyzed by reverse phase chromatography andWestern blot analysis. Reverse phase HPLC was performed using an YMC-pack
PROTEIN-RP column (4.6  250 mm) as described in Section 2. The separated proteins were collected in 1.0 ml fractions and concentrated using a centrifugation concentrator
system (Sakuma, Tokyo, Japan) for further analysis. After concentration, all fractions (3–50 min) were subjected to Western blot analysis with anti-Prx2 antibody after 12%
SDS–PAGE and transfer to a PVDF membrane. RBC lysates were prepared after treatment with 500 lM H2O2 (B), t-BHP (C) or without peroxide (A). A typical result from the
other three samples providing similar results is presented.
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hyperoxidation of Prx2 was observed (data not shown).
In contrast, the intensity of the peak corresponding to native
Prx2 (Peak-b, Fig. 1C) decreased following treatment with t-BHP,
which is more hydrophobic than H2O2. Concomitant with the
decrease in native Prx2 (Peak-b), a new peak appeared at a reten-
tion time of 46 min (Peak-c, Fig. 1C). Quantitative analysis of the
Prx2 peaks showed that these alterations occurred in a t-BHP
concentration-dependent manner (Fig. 2). Although it is likely that
t-BHP-induced hyperoxidation is more obvious at high concentra-
tions, a low concentration (100 lM) of t-BHP signiﬁcantly hyper-
oxidized Prx2 in human RBCs (Fig. 2).
Second, for a more detailed assessment of the separation capac-
ity of Prx2 in the present HPLC system, protein composition in the
Prx2-detected fractions (Peak-a and Peak-c) was evaluated by SDS–
PAGE followed by silver staining. As shown in Fig. 3, the most
prominent bands detected in both fractions (bands No. 1 and No.0
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Fig. 2. Dose dependent alterations in peak areas obtained by reverse phase
chromatography. HPLC was performed using a reverse phase column for proteins,
as described in Section 2. RBC lysates were prepared after treatment with 0–500 lM
t-BHP. Peak b and Peak c are indicated on the chromatogram as shown in Fig. 1B.2) were proteins of 23 kDa. Using in-gel digestion and PMF
(MALDI–TOF–TOF-MS), proteins derived from bands No. 1 and
No. 2 were both identiﬁed as human Prx2 (Accession; Uni-
protKB:P32119) with sequence coverages of 51.5% and 65.7%,
respectively.
To clarify the oxidative status of Prx2, two-dimensional (2D)
electrophoresis of the t-BHP-treated sample was performed,1 2
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Fig. 3. Protein identiﬁcation by MS analysis. RBCs were treated with or without
500 lM t-BHP and proteins contained in fractions corresponding to peaks a and c in
Fig. 1 were prepared. The proteins were separated using 12% SDS–PAGE and
detected by silver staining. Protein bands No. 1 and No. 2 were excised and
subjected to in-gel digestion and PMF using MALDI–TOF–TOF-MS. Proteins derived
from bands No. 1 and No. 2 were identiﬁed as human Prx2 (Accession; P32119).
Anti-Prx2
Anti-Prx-SO2/3
23kDa
23kDa
1
2
3
4
5
0 10 20 30 40 50 60
m
V
Time (min)
t-BHP treated sample
b c
Fig. 5. Oxidative status of Prx2 in human RBCs following t-BHP treatment. An RBC
lysate was prepared after treatment with 500 lM t-BHP. After concentration, each
fraction was subjected to Western blot analysis with anti-Prx2 antibody (A; upper
image) and reprobed with anti-Prx-SO2/3 antibody (B; lower image). Peaks b and c
are indicated on the chromatogram. A typical result from two other samples
exhibiting similar responses is presented.
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spots of equal molecular weight with pI values of 5.8 and 5.4; the
more acidic spot (pI 5.4) is more clearly observed in the t-BHP-
treated sample compared to the control sample (Fig. 4). Further-
more, the two peaks obtained from the oxidized samples by
reverse phase HPLC were also examined by immunoblotting. While
similar band intensities (23 kDa) were observed for both peaks
detected with the anti-Prx2 antibody, anti-PrxSO2/3 immunoreac-
tivity was markedly increased in Peak-c compared to Peak-b
(Fig. 5). These results indicated that the native and hyperoxidized
forms of Prx2 were separated by our HPLC system.
4. Discussion
Prxs are a widespread family of cysteine-dependent peroxi-
dases, and their oxidation state is presumed to be involved in other
functions such as chaperone activity [14]. Using antibodies speciﬁc
for sulﬁnic and sulfonic acids (Prx-SO2/3), various examples have
been found of Prx hyperoxidation in physiologically relevant
events. Given the need to better understand the biological roles
of Prx hyperoxidation, it is important to be able to characterize this
property in the Prx family. We have recently focused our attention
on the physiological signiﬁcance of Prx2, which is abundant in
RBCs, and have found that the oligomers consisting of the reduced
form of Prx2 in human RBCs exhibit chaperone activity nearly
equal to that of the hyperoxidized form [15]. Thus, real-time mon-
itoring of the hyperoxidation status was suggested to be signiﬁcant
for studying the physiological roles of Prxs.
In this study, we developed a reverse-phase HPLC-based
method for the rapid separation of reduced and hyperoxidized
Prx2 using human RBCs as the sample, in which the activity of
the reversible redox system is low. In the present method, the
sample preparation and assay procedures were shown to easily
separate and detect the reduced and hyperoxidized forms of
Prx2. Therefore, this method is more useful than 2D-PAGE with
Western blot analysis in yielding accurate results that reﬂect the
hyperoxidative status of human RBCs. Indeed, the present study
demonstrated that the detection of Prx2 hyperoxidation and
estimation of the protein oxidation state can occur within 2 h after
blood sampling. To verify the production and accumulation of the
hyperoxidized form of Prx2 in RBCs, we also estimated the oxida-
tive status using 2D electrophoresis/Western blot analysis.
As shown in Fig. 4, signiﬁcant spots that have maintained the pI
of native Prx2 were detected with anti-Prx-SO2/3 antibody. It isFig. 4. Oxidative status of Prx2 in human RBCs analyzed by 2D-PAGE and Western
blot analysis. Prx2 from freshly obtained RBCs that were untreated (A) or treated (B)
with 500 lM t-BHP was subjected to 2D-PAGE as described in Section 2. The
separated and transferred proteins were detected by Western blotting with anti-
Prx2 (upper image) or anti-Prx-SO2/3 (lower image). A typical result from two other
samples exhibiting similar responses is presented.likely that these spots observed are artiﬁcially hyperoxidized pro-
teins produced after the separation by isoelectric focusing followed
by PAGE and Western blot analysis, as very little peak correspond-
ing to hyperoxidized Prx2 was observed in the HPLC results for the
same untreated sample (Fig. 1B), and a faint band was observed
with anti-Prx-SO2/3 antibody for the same t-BHP treated sample
(Fig. 5). Concurrently, good separation between the reduced and
hyperoxidized forms of Prx2 was achieved when reversed phase
HPLC was utilized to assess Prx2 in RBC samples. The peaks on
the chromatogramwere identiﬁed using MALDI–TOF-MS. Observa-
tion of hyperoxidized Prx2, formed upon exposure to cytotoxic
ROS, revealed that Prx2 in RBCs might be refractory to oxidation
by peroxides, since the hyperoxidized form was produced upon
exposure to t-BHP (100–500 lM) but not to H2O2 (500 lM). In
addition to Prx2, protein bands of 27 kDa and 53 kDa were
detected in control and t-BHP treated fractions, respectively. These
proteins are likely to be Prx2-binding proteins whose interaction is
affected by the hyperoxidative status of Prx2, although there are
other possible explanations, such as accidental coincidence due
to equivalent retention times.
Rhee and co-workers provided the ﬁrst LC–Q–TOF-MS evidence
for reversible conversion of cysteine residues of Prx1, 2, and 3 to sul-
ﬁnic acid (–SO2) in a rat macrophage-derived cell line [16,17].
Moreover, they reported that Cys residues in yeast Prx1 are hyper-
oxidized to sulfonic acid (–SO3), based on TOF-MS analysis [18].
Rabilloud et al. reported that a sensitive cysteine, Cys-51, was
shown to be oxidized to cysteine sulfonic acid by t-BHP, leading
to the formation of an inactivated form of Prx2 in human T-lym-
phoma cells [19]. However, there are insufﬁcient studies dealing
with the oxidation status of freshly prepared Prx2 from human
RBCs, since detailed analysis requires long periods of time for 2D
electrophoresis following by Western blot analysis. Our HPLC-
based method is not only rapid, but also more useful for quantita-
tion in comparison with Western blot analysis after separation by
2D-PAGE, which provides qualitative rather than quantitative data.
Indeed, it is indicated that the antibodies available typically recog-
nize sulfonic acid forms more strongly than native forms [20].
852 Y.I. Ishida et al. / FEBS Open Bio 4 (2014) 848–852Yang et al. reported that H2O2-hyperoxidized recombinant
human Prx1 eluted earlier than native Prx1 from a reverse-phase
HPLC system [21]. The hyperoxidized Prx2 in human RBCs treated
by t-BHP was retained more strongly by the reverse-phase HPLC
column than native Prx2. Thus, we propose that the hydrophobic-
ity is not only dependent on the oxidation state of the Cys-51
residue, but also on the steric conformation of oxidized Prx2. Our
results appear to indicate that a form of hyperoxidized Prx2 was
altered to become more hydrophobic than native Prx2.
In conclusion, the present study suggests that the oxidation-
susceptible Cys residue of Prx2 from human RBC was oxidized into
a hyperoxidized (sulﬁnic and sulfonic acids) derivative by t-BHP.
This puriﬁcation procedure might be applied to real-time assays
for detecting reduced and hyperoxidized Prx2. Consequently, this
method may enable determination of the oxidative status and
redox balance in Prx2 in vivo. Further investigations using this
method into the physiological function of Prx2 and its application
to clinical specimens are expected in the near future.
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